Back to search

Article

Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18 labeled tetrazine

2025-08-07

Abstract excerpt

<title>Abstract</title> <p>Background Antibody-based positron emission tomography (PET) imaging holds great promise for visualizing disease-related proteins in the brain. However, its clinical utility is limited by poor antibody penetration across the blood-brain barrier (BBB) and the requirement for long-lived radionuclides due to slow antibody pharmacokinetics. Pretargeted imaging strategies, in which antibody...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d03d6e44-5462-5c06-8597-5a9357f634b1
DOI
10.21203/rs.3.rs-7235104/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18 labeled tetrazineDOI 10.21203/rs.3.rs-7235104/v1
Select a neighboring publication to make it the new centre.